0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Rescue Strategy for Handling Unevaluable Patients in Simon’s Two Stage Design

      research-article
      1 , 2 , * , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9
      PLoS ONE
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          For phase II oncology trials, Simon’s two-stage design is the most commonly used strategy. However, when clinically unevaluable patients occur, the total number of patients included at each stage differs from what was initially planned. Such situations raise concerns about the operating characteristics of the trial design. This paper evaluates three classical ad hoc strategies and a novel one proposed in this work for handling unevaluable patients. This latter is called the rescue strategy which adapts the critical stopping rules to the number of unevaluable patients at each stage without modifying the planned sample size. blue Simulations show that none of these strategies perfectly match the original target constraints for type I and II error rates. Our rescue strategy is nevertheless the one which best approaches the target error rates requirement. A re-analysis of one real phase II clinical trials on metastatic cancer illustrates the use of the proposed strategy.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          One-sample multiple testing procedure for phase II clinical trials.

          T Fleming (1982)
          Commonly, the central objective of Phase II clinical trials is the assessment of the antitumor 'therapeutic efficacy' of a specific treatment regimen. It is of interest to formulate test procedures which can be employed in these trials to decide whether or not this therapeutic efficacy warrants further investigation. For ethical reasons, these procedures should allow for early termination if initial results are extreme. In this paper, a one-sample multiple testing procedure is proposed which employs the standard single-stage test procedure at the last test, and which both allows for early termination and essentially preserves the size, power and simplicity of the single-stage procedure.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Proper inference from Simon's two-stage designs.

              Simon's two-stage designs are very popular for phase II clinical trials. A literature review revealed that the inference procedures used with Simon's designs almost always ignore the actual sampling plan used. Reported P-values, point estimates and confidence intervals for the response rate are not usually adjusted for the design's adaptiveness. In addition, we found that the actual sample size for the second stage is often different from that planned. We present here a method for inferences using both the planned and the actual sample sizes. The conventional and the preferred inference procedures usually yield similar P-values and confidence intervals for the response rate. The conventional inference, however, may contradict the result of the corresponding hypothesis testing.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                2015
                14 September 2015
                : 10
                : 9
                : e0137586
                Affiliations
                [1 ]Biostatistics department, Hôpital, Institut Curie, Paris, France
                [2 ]UMR 1178, INSERM, Villejuif, France
                [3 ]Université Paris Sud, Villejuif, France
                [4 ]Hôpital Paul Brousse, AP-HP, Villejuif, France
                [5 ]Epidemiology and Clinical Research department, Hôpital Bichat, AP-HP, Paris, France
                [6 ]Centre de pharmacoépidémiologie (Cephepi), Hôpital Bichat, AP-HP, Paris, France
                [7 ]UMR 1123 ECEVE, Université Paris Diderot, Sorbonne Paris Cité, Paris, France
                [8 ]UMR 1123 ECEVE, INSERM, Paris, France
                [9 ]CIC-EC 1425, INSERM, Paris, France
                Yale School of Public Health, UNITED STATES
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                Conceived and designed the experiments: LB PB YdR. Performed the experiments: LB. Analyzed the data: LB. Contributed reagents/materials/analysis tools: LB PB YdR. Wrote the paper: LB PB YdR.

                Article
                PONE-D-15-14545
                10.1371/journal.pone.0137586
                4569274
                26368810
                1a047557-f8ec-4296-9c11-27e90ee9d31f
                Copyright @ 2015

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

                History
                : 8 April 2015
                : 18 August 2015
                Page count
                Figures: 2, Tables: 6, Pages: 14
                Funding
                The authors have no support or funding to report.
                Categories
                Research Article
                Custom metadata
                Data are subject to ethical restrictions for patient privacy. Data requests can be sent the Curie Institute Ethics Committee for researchers who meet the criteria for access to confidential data. Data could be requested by contacting Dr Kirova: youlia.kirova@ 123456curie.fr .

                Uncategorized
                Uncategorized

                Comments

                Comment on this article